PharVision Advisers’s Brinker International EAT Stock Holding History

PharVision Advisers’s Portfolio EAT Stock Details EAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,520	Closed	-$649K	–	267
2025 Q4	$649K	Buy	4,520 +902	+25%	+$118K	0.33%	7
2025 Q3	$458K	Buy	3,618 +2,394	+196%	+$374K	0.26%	37
2025 Q2	$221K	Buy	+1,224	New	+$192K	0.32%	174
2025 Q1	–	Sell	-1,534	Closed	-$203K	–	337
2024 Q4	$203K	Buy	+1,534	New	+$173K	0.17%	300

Other funds holding EAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PharVision Advisers's EAT Position: Q1 2026 in Review

PharVision Advisers sold out of Brinker International (EAT) in Q1 2026, closing a stake of 4,520 shares — an estimated $649K sold.

PharVision Advisers first reported a position in EAT in Q4 2024 and held it in 4 quarters. The position peaked at $649K in Q4 2025. 464 funds tracked by Wall St. Rank hold EAT as of Q1 2026.

PharVision Advisers reported no remaining Brinker International position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 4,520 Brinker International shares in Q1 2026, an estimated $649K.
PharVision Advisers first reported a position in Brinker International in Q4 2024 and held it in 4 quarters.
PharVision Advisers's Brinker International position peaked at $649K in Q4 2025.
464 funds tracked by Wall St. Rank held Brinker International as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.